Immuron Ltd Files 6-K for December 2025
Ticker: IMRN · Form: 6-K · Filed: Dec 5, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Dec 5, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Immuron Ltd filed its monthly 6-K, confirming 20-F filing status. No major news.
AI Summary
Immuron Limited filed a Form 6-K on December 5, 2025, reporting on its activities for the month of December 2025. The filing indicates that the company is a foreign private issuer and will file annual reports under Form 20-F. No specific financial figures or operational updates were detailed in this particular filing.
Why It Matters
This filing serves as a routine update for investors and regulators, confirming Immuron's status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no new material financial or operational information that would immediately impact risk.
Key Players & Entities
- Immuron Limited (company) — Registrant
- 001-38104 (company) — Commission File Number
- Form 20-F (company) — Annual Report Form
- Form 6-K (company) — Filing Type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange on which its securities are traded.
What is Immuron Limited's filing status regarding annual reports?
Immuron Limited indicates it files annual reports under cover of Form 20-F.
Does Immuron Limited furnish information under Rule 12g3-2(b)?
No, Immuron Limited indicated 'No' for furnishing information under Rule 12g3-2(b).
What is the principal executive office address for Immuron Limited?
The principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
What is the SIC code for Immuron Limited?
The Standard Industrial Classification (SIC) code for Immuron Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 310 words · 1 min read · ~1 pages · Grade level 17.2 · Accepted 2025-12-05 08:00:10
Filing Documents
- ea0268607-6k_immuron.htm (6-K) — 12KB
- ea026860701ex99-1_immuron.htm (EX-99.1) — 38KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-118471.txt ( ) — 54KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on December 5, 2025 titled: 99.1 Application for quotation of securities A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Application for quotation of securities 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: December 5, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3